子類別 會議論文/會議摘要 [1/3] 期刊論文 [13/13] 鄰近社群 于重元 [19/19] 劉柯俊 [85/98] 劉滄梧 [119/125] 劉界元(2003-2010) [3/3] 夏和雄(1996-2012) [26/31] 夏興國 [51/54] 姜乃榕 [82/94] 常慧如 [39/44] 張俊彥 [234/254] 張光裕 [69/79] 張憶壽 [103/106] 張文祥 [52/53] 張書銘 [89/91] 彭汪嘉康(1996-2007) [120/126] 施能耀 [37/43] 李家惠 [29/29] 李岳倫 [48/49] 林素芳 [32/32] 楊奕馨 [41/42] 江士昇 [88/90] 洪文俊 [88/88] 莊雙恩 [82/91] 蔡坤志 [32/34] 蔡慧珍 [66/71] 蘇勇曄 [40/40] 蘇振良 [24/25] 郭靜娟 [71/76] 陳尚鴻 [45/48] 陳振陽 [72/72] 陳立宗 [443/510] 陳美霞(2002-2009) [1/1] 陳詩政 [2/2] 陳雅雯 [38/39] 黃智興 [55/55] 黃道揚 [26/26] 丁兆治(2000-2004) [5/5] 其他 [464/471] 劉敏(1996-2007) [60/62] 劉玫英(2004-2006) [2/2] 吳成文(1996-2008) [53/55] 曾思文(1997-2007) [4/4] 李冠德(1997-2004) [4/6] 林景太(1999-2007) [5/5] 楊文光(1996-1999) [21/21] 王全正(1996-2003) [4/4] 莊聲宏(1997-2004) [11/11] 詹宗晃(2000-2008) [2/2] 賴基銘(2004-2008) [41/47] 阮麗蓉(2000-2006) [6/7] 陳俊叡(2003-2007) [6/6] 馬彥英(1997-1999) [1/1] 黃奇英(2005-2007) [9/10] 社群統計 近3年內發表的文件:9(56.25%) 含全文筆數:14(87.50%) 文件下載次數統計 下載大於0次:14(100.00%) 下載大於100次:11(78.57%) 檔案下載總次數:2820(0.05%) 最後更新時間: 2024-12-01 20:32 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 DKK1 as a chemoresistant protein mo... APLF facilitates interstrand DNA cr... RNF43 inactivation enhances the B-R... Exon junction complex mediates the ... PARP1 recruits DNA translocases to ... CHK2 activation contributes to the ... Low expression of cytosolic NOTCH1 ... STAG2 regulates interferon signalin... TRPM1 promotes tumor progression in... AUY922 induces retinal toxicity thr...

跳至: (選擇年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目1-16 / 16. (共1頁) 1  每頁顯示[10|25|50]項目

日期	題名	關聯
2024-09-27	DKK1 as a chemoresistant protein modulates oxaliplatin responses in colorectal cancer	Oncogenesis. 2024 Sep 27;13:Article number 34.
2024-06-10	APLF facilitates interstrand DNA crosslink repair and replication fork protection to confer cisplatin resistance	Nucleic Acids Research. 2024 Jun 10;52(10):5676-5697.
2024-03	RNF43 inactivation enhances the B-RAF/MEK signaling and greates a combinatory therapeutic target in cancer cells	Advanced Science. 2024 Mar;11(12):Article number e2304820.
2023-11-01	Exon junction complex mediates the cap-independent translation of circular RNA	Molecular Cancer Research. 2023 Nov 1;21(11):1220-1233.
2023-01	TRPM1 promotes tumor progression in acral melanoma by activating the Ca2+/CaMKIIdelta/AKT pathway	Journal of Advanced Research. 2023 Jan;43:45-57.
2022-12	PARP1 recruits DNA translocases to restrain DNA replication and facilitate DNA repair	PLoS Genetics. 2022 Dec;18(12):Article number e1010545.
2022-11	CHK2 activation contributes to the development of oxaliplatin resistance in colorectal cancer	British Journal of Cancer. 2022 Nov;127(9):1615-1628.
2022-05-15	Low expression of cytosolic NOTCH1 predicts poor prognosis of breast cancer patients	American Journal of Cancer Research. 2022 May 15;12(5):2084-2101.
2022-04-06	STAG2 regulates interferon signaling in melanoma via enhancer loop reprogramming	Nature Communications. 2022 Apr 06;13:Article number 1859.
2021-07-23	AUY922 induces retinal toxicity through attenuating TRPM1	Journal of Biomedical Science. 2021 Jul 23;28:Article number 55.
2021-01-19	NECTIN4: A novel therapeutic target for melanoma	International Journal of Molecular Sciences. 2021 Jan 19;22(2):Article number 976.
2020-08	Mutation of the STK11 gene predicts recurrence of breast cancer	Cancer Research. 2020 Aug;80(16):Abstract number 2487.
2020-05	Modulating tumor immune microenvironment by the STK11/LKB1 signaling in breast cancer	Journal of Clinical Oncology. 2020 May;38(15, Suppl.):Abstract number e15185.
2020-03-04	Immunohistochemical BRAF V600E expression and intratumor BRAF V600E heterogeneity in acral melanoma: Implication in melanoma-specific survival	Journal of Clinical Medicine. 2020 Mar 4;9(3):Article number 690.
2019-09	Prognostic and clinicopathologic associations of Casein Kinase (CK) 1 alpha in acral lentiginous melanoma	Journal of Investigative Dermatology. 2019 Sep;139(9):S299.
2019-02-18	The potential of targeting P53 and HSP90 overcoming acquired MAPKi-Resistant melanoma	Current Treatment Options in Oncology. 2019 Feb 18;20(3):Article number 22.

顯示項目1-16 / 16. (共1頁) 1  每頁顯示[10|25|50]項目